IP Library Granted Patent US 7,521,244
Granted Patent B2
US 7,521,244 · App. 11/588,160 · Granted Apr 21, 2009

Standard reference solutions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,521,244
App. No.
11/588,160
Granted
Apr 21, 2009
Kind
B2
Abstract

Standard reference materials and related methods are described for quality testing and calibration of instruments used for the qualitative and quantitative determination of hemoglobin and glycated hemoglobin as well as other analytes of interest in animal tissue samples. The reference solutions of the disclosure utilize a synthetic cruor in combination with an Hb peptide chain.

Claims (30)

1. A standard reference composition comprising a synthetic cruor and a synthetic Hb peptide chain, and further comprising glucose.

2. The standard reference composition of claim 1 , wherein the synthetic cruor has a main absorption maxima at a wavelength between about 450 to about 650 nrn.

3. The standard reference composition of claim 2 , wherein the synthetic cruor is selected from the group consisting of sulforhodamine B, sulforhodamine red, Congo Red, Mito Red, Acid Red, Fluorescent Red, Allura Red, Cresol Red, Amaranth, chiorophenol red, xylenol orange, sulforhodamine 101 and combinations thereof.

4. The standard reference composition of claim 1 , wherein the synthetic Hb peptide chain comprises 5 amino acids.

5. The standard reference composition of claim 4 , wherein the synthetic Hb peptide chain is glycated.

6. The standard reference composition of claims 1 or 5 , further comprising a preservative.

7. The standard reference composition of claim 1 or 5 , further comprising a chelator.

8. The standard reference composition of claim 1 , further comprising one or more analytes selected from the group consisting of microalbumin, ketone, and creatine.

9. The standard reference composition of claim 1 , wherein the synthetic Hb peptide chain includes UbAI.

10. The standard reference composition of claim 9 , wherein the synthetic Hb peptide chain includes HbAlc.

11. A method of quality control of a diagnostic device comprising:

providing to a diagnostic device an aliquot of a standard reference composition comprising a synthetic cruor and an Hb peptide;

wherein the synthetic cruor 15 present in a sufficient amount to provide the standard reference composition with a predetermined level of total hemoglobin, and the Hb peptide is present in a sufficient amount to provide the standard reference composition with a predetermined level of glycated hemoglobin;

quantitating in the diagnostic device the synthetic cruor in the standard reference composition;

quantitating in the diagnostic device the Hb peptide in the standard reference composition;

comparing the quantitations of the synthetic cruor and the Hb peptide in the standard reference with the predetermined amount of total hemoglobin and glycated hemoglobin to check the accuracy of the diagnostic device and

wherein the standard reference composition further comprises glucose in a sufficient amount to provide the standard reference composition with a predetermined amount of glucose and further comprising the steps of:

quantitating in the diagnostic device the glucose in the standard reference composition; and

comparing the quantitations of the glucose in the standard reference with the predetermined levels of the glucose to check the accuracy of the diagnostic device.

12. A method of quality control of a diagnostic device comprising:

providing to a diagnostic device an aliquot of a standard reference composition comprising a synthetic cruor and an Hb peptide;

wherein the synthetic cruor and the Hb peptide are present in a sufficient amount to provide the standard reference composition with a predetermined fraction of Hb peptide/synthetic cruor;

quantitating in the diagnostic device the fraction of Hb peptide/synthetic cruor in the standard reference composition;

comparing the quantitation of the fraction of Hb peptide/synthetic cruor in the standard reference with the predetermined fraction of Hb peptide/synthetic cruor to check the accuracy of the diagnostic device; and

wherein the standard reference composition further comprises glucose in a sufficient amount to provide the standard reference composition with a predetermined amount of glucose and further comprising the steps of:

quantitating in the diagnostic device the glucose in the standard reference composition; and comparing the quantitation of the glucose in the standard reference composition with the predetermined levels of the glucose to check the accuracy of the diagnostic device.

13. The method of claim 11 or 12 , wherein the standard reference composition further comprises an additional analyte selected from the group consisting of microalburnin, ketone, and creatine in a sufficient amount to provide the standard reference composition with a predetermined amount of the additional analyte and further comprising:

quantitating in the diagnostic device the additional analyte in the standard reference composition; and comparing the quantitation of the additional analyte in the standard reference composition with the predetermined amount of the additional analyte to check the accuracy of the diagnostic device.

14. The method of claim 11 or 12 , wherein providing an aliquot of a standard reference composition comprising a synthetic cruor and an Hb peptide comprises providing an HbAI peptide.

15. The method of claim 14 , wherein providing an UbAl peptide comprises providing an HbAlc peptide.

Assignments (7)
SECURITY AGREEMENT Recorded Jul 26, 2013
From: BROWN BROTHERS HARRIMAN & CO.
To: BIONOSTICS, INC.; BIONOSTICS HOLDINGS, LTD.; BIONOSTICS, LTD.; OXFORD CRYOSYSTEMS, LTD.; OXFORD CRYOSYSTEMS, INC.
Reel/Frame 030889/0976 →
SECURITY AGREEMENT Recorded Aug 4, 2010
From: BIONOSTICS, INC.; BIONOSTICS HOLDINGS, LTD.; BIONOSTICS LTD.; OXFORD CRYOSYSTEMS, LTD.; OXFORD CRYOSYSTEMS, INC.
To: BROWN BROTHERS HARRIMAN & CO., AS ADMINISTRATIVE AGENT
Reel/Frame 024785/0059 →
RELEASE OF SECURITY INTEREST Recorded Aug 3, 2010
From: FORTRESS CREDIT CORP., AS ADMINISTRATIVE AGENT
To: BIONOSTICS, INC.; OXFORD CRYOSYSTEMS, INC.; BIONOSTICS HOLDINGS LIMITED; BIONOSTICS LIMITED; OXFORD CRYOSYSTEMS LIMITED
Reel/Frame 024776/0409 →
CHANGE OF NAME Recorded Sep 23, 2008
From: FERRARIS GROUP, INC.
To: BIONOSTICS, INC.
Reel/Frame 021570/0158 →
MERGER Recorded Sep 23, 2008
From: FERRARIS GROUP, INC.; BIONOSTICS, INC.
To: FERRARIS GROUP, INC.
Reel/Frame 021570/0185 →
SECURITY AGREEMENT Recorded Jul 23, 2008
From: BIONOSTICS INC.; BIONOSTICS LIMITED; OXFORD CRYOSYSTEMS INC.; FERRARIS GROUP, INC.; OXFORD CRYOSYSTEMS LIMITED; NAV BIDCO LIMITED
To: FORTRESS CREDIT CORP.
Reel/Frame 021283/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2006
From: RANNIKKO, MINNA A.; CONNORS, DONNA; RAFFERTY, DONNA
To: BIONOSTICS, INC.
Reel/Frame 018693/0044 →